{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:19:02Z","timestamp":1793521142547,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report the clinical profile and outcomes of acute Vogt\u2013Koyanagi\u2013Harada disease with a strict immunosuppression regimen and investigate the risk factors for a prolonged disease course.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 101 patients with acute Vogt\u2013Koyanagi\u2013Harada (202 eyes) with more than 24 months of follow-up were recruited from January 2011 to June 2020. They were divided into two groups according to the interval between the onset of Vogt\u2013Koyanagi\u2013Harada and treatment. Oral prednisone was gradually tapered off by a diminished dose according to a relatively strict protocol. Patient responses to the treatment regimen were classified as long-term drug-free remission or chronic recurrent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Ninety-six patients (95.0%) achieved long-term drug-free remission without recurrence, while 5 (5.0%) had chronic recurrence. Most patients achieved good best-corrected visual acuity (90.6% \u226720\/25). A generalized estimation equation model demonstrated that time of visit, ocular complications, and cigarette smoking were independent risk factors for a longer disease course, and smokers required a higher drug dose and longer treatment course than nonsmokers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>An immunosuppressive regimen with an appropriate tapering speed can lead to long-term drug-free remission in patients with acute Vogt\u2013Koyanagi\u2013Harada. Cigarette smoking significantly affects ocular inflammation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003837","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T21:00:33Z","timestamp":1684962033000},"page":"1496-1505","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT\u2013KOYANAGI\u2013HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN"],"prefix":"10.1097","volume":"43","author":[{"given":"Kaixuan","family":"Wang","sequence":"first","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Tangshan Eye Hospital, Tangshan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqin","family":"Tao","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Cheng","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-4152","authenticated-orcid":false,"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2016.05.002","article-title":"Vogt-Koyanagi-Harada disease","volume":"62","author":"O'Keefe","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ophtha.2006.07.040","article-title":"Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients","volume":"114","author":"Yang","year":"2007","journal-title":"Ophthalmology"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.autrev.2016.04.001","article-title":"Vogt-Koyanagi-Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options","volume":"15","author":"Silpa-Archa","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/02713680500263606","article-title":"Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China","volume":"30","author":"Yang","year":"2005","journal-title":"Curr Eye Res"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.preteyeres.2016.02.002","article-title":"Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment","volume":"52","author":"Du","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00417-017-3654-5","article-title":"The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease","volume":"255","author":"Park","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","article-title":"Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease","volume":"142","author":"Read","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/eye.2008.89","article-title":"Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease","volume":"23","author":"Lai","year":"2009","journal-title":"Eye"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajo.2020.07.036","article-title":"Vogt-Koyanagi-Harada disease managed with immunomodulatory therapy within 3 months of disease onset","volume":"220","author":"Ei Ei Lin","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00417-014-2904-z","article-title":"High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids","volume":"253","author":"Sakata","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ophtha.2015.02.034","article-title":"Association between smoking and uveitis: results from the pacific ocular inflammation study","volume":"122","author":"Yuen","year":"2015","journal-title":"Ophthalmology"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjophthalmol-2017-311691","article-title":"Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids","volume":"103","author":"Nakayama","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1111\/aos.12127","article-title":"Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids","volume":"91","author":"Abu El-Asrar","year":"2013","journal-title":"Acta Ophthalmologica"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12886-020-01656-x","article-title":"Vogt-Koyanagi-Harada disease: a retrospective and multicentric study of 41 patients","volume":"20","author":"Diallo","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10792-006-9009-6","article-title":"Spectrum of Vogt-Koyanagi-Harada disease in Singapore","volume":"27","author":"Chee","year":"2007","journal-title":"Int Ophthalmol"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/09273948.2013.856448","article-title":"Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey","volume":"22","author":"Ozdal","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10792-007-9060-y","article-title":"Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up","volume":"27","author":"Herbort","year":"2007","journal-title":"Int Ophthalmol"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2415-12-40","article-title":"Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study","volume":"12","author":"da Silva","year":"2012","journal-title":"BMC Ophthalmol"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/02713683.2017.1383444","article-title":"Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents","volume":"43","author":"Yang","year":"2018","journal-title":"Curr Eye Res"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/aos.13189","article-title":"Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease","volume":"95","author":"Abu El-Asrar","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajo.2019.06.032","article-title":"Glucocorticoid receptor-alpha and MKP-1 as candidate biomarkers for treatment response and disease activity in Vogt-Koyanagi-Harada disease","volume":"207","author":"Urzua","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1167\/iovs.16-20783","article-title":"Evaluation of the glucocorticoid receptor as a biomarker of treatment response in Vogt-Koyanagi-Harada disease","volume":"58","author":"Urzua","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10792-006-9013-x","article-title":"The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, north africa","volume":"27","author":"Khairallah","year":"2007","journal-title":"Int Ophthalmol"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s10792-018-0949-4","article-title":"Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease","volume":"39","author":"Herbort","year":"2019","journal-title":"Int Ophthalmol"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0002-9394(01)00937-0","article-title":"Complications and prognostic factors in Vogt-Koyanagi-Harada disease","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00417-010-1597-1","article-title":"Smoking complicates the course of non-infectious uveitis","volume":"249","author":"Roesel","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R30-20250605","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ophtha.2009.08.011","article-title":"Cigarette smoking as a risk factor for uveitis","volume":"117","author":"Lin","year":"2010","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:08:03Z","timestamp":1749143283000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003837","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}